MedTrace Logo

Barrett's Esophagus & Gastroesophageal Reflux Disease

NCT00513331 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2014-01-01

No results posted yet for this study

Summary

This is a study of Barrett's Esophagus (BE) and Gastroesophageal Reflux Disease (GERD). It aims to look at the long term efficacy of evidence-based cutting edge diagnostic and therapeutic algorithms and techniques such as radiofrequency ablation, endoscopic mucosal resection and surveillance endoscopy with biopsy. Additionally, biological analyses will be performed in hopes of identifying biomarkers associated with the progression of BE to esophageal cancer.

Conditions

  • Barrett's Esophagus
  • GERD

Interventions

PROCEDURE

Endoscopy

Initial Assessment for lesions can be based on information obtained from previous upper endoscopies and or pathology reports. Repeat Endoscopic assessments are based on initial and follow-up assessments.

PROCEDURE

Radiofrequency ablation protocol

Ablation using the HALO 360 system according to protocol established by BARRX, Inc.

PROCEDURE

Endoscopic mucosal resection protocol

Excision of lesion using DUETTE, marketed by Wilson-Cook

Sponsors & Collaborators

  • Valley Health System

    lead OTHER

Principal Investigators

  • Robert J. Korst, MD · Valley Health Systems/ The Valley Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00513331 on ClinicalTrials.gov